Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental Reservoirs

Cell Host Microbe. 2019 Nov 13;26(5):650-665.e4. doi: 10.1016/j.chom.2019.10.011.

Abstract

Antibiotics alter microbiota composition and increase infection susceptibility. However, the generalizable effects of antibiotics on and the contribution of environmental variables to gut commensals remain unclear. To address this, we tracked microbiota dynamics with high temporal and taxonomic resolution during antibiotic treatment in a controlled murine system by isolating variables such as diet, treatment history, and housing co-inhabitants. Human microbiotas were remarkably resilient and recovered during antibiotic treatment, with transient dominance of resistant Bacteroides and taxa-asymmetric diversity reduction. In certain cases, in vitro sensitivities were not predictive of in vivo responses, underscoring the significance of host and community context. A fiber-deficient diet exacerbated microbiota collapse and delayed recovery. Species replacement through cross housing after ciprofloxacin treatment established resilience to a second treatment. Single housing drastically disrupted recovery, highlighting the importance of environmental reservoirs. Our findings highlight deterministic microbiota adaptations to perturbations and the translational potential for modulating diet, sanitation, and microbiota composition during antibiotics.

Keywords: Bacteroides; S24-7; antibiotics; co-housing; coprophagia; fecal microbiota transplants; gut microbiota; microbiota perturbations; reseeding; resilience.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Load / drug effects*
  • Bacteroides / classification
  • Bacteroides / growth & development*
  • Bacteroides / isolation & purification
  • Biodiversity
  • Ciprofloxacin / pharmacology
  • Diet
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Tract / drug effects
  • Gastrointestinal Tract / microbiology*
  • Germ-Free Life
  • Humans
  • Male
  • Mice
  • Rifaximin / pharmacology
  • Streptomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Rifaximin
  • Streptomycin